M. Cairo

Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density.

K. Hess, Jenny C. Chang, F. Meric-Bernstam, 2009 .

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.

M. Burotto, L. Fallowfield, S. Margolin, 2021, European journal of cancer.

Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density

P. Brown, K. Hess, G. Hortobagyi, 2009, Breast Cancer Research and Treatment.